The resulting BCR-ABL1 fusion protein displays constitutive kinase activity, driving unchecked cell growth in several types of leukemia, such as Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) [23]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.